Sebastian Wanless
Corporate Officer/Principal bei TCB Newco Ltd.
Aktive Positionen von Sebastian Wanless
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
TCB Newco Ltd.
 TCB Newco Ltd. Pharmaceuticals: MajorHealth Technology TCB Newco Ltd. provides clinical services. It develops CAR-T cell therapy products for the treatment of cancer, as well as developing gamma delta T cell therapies for the treatment of infectious disease. The company was founded on July 5, 2021 and is headquartered in Motherwell, GB. | Corporate Officer/Principal | - | - |
Karriereverlauf von Sebastian Wanless
Ehemalige bekannte Positionen von Sebastian Wanless
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| TC BIOPHARM (HOLDINGS) PLC | Corporate Officer/Principal | 01.09.2020 | 01.09.2022 |
| Bristol-Myers Squibb Foundation | Corporate Officer/Principal | 01.01.2003 | 01.01.2007 |
Statistik
International
| Vereinigtes Königreich | 3 |
| Vereinigte Staaten | 2 |
Operativ
| Corporate Officer/Principal | 3 |
Sektoral
| Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| TC BIOPHARM (HOLDINGS) PLC | Health Technology |
| Private Unternehmen | 2 |
|---|---|
TCB Newco Ltd.
TCB Newco Ltd. Pharmaceuticals: MajorHealth Technology TCB Newco Ltd. provides clinical services. It develops CAR-T cell therapy products for the treatment of cancer, as well as developing gamma delta T cell therapies for the treatment of infectious disease. The company was founded on July 5, 2021 and is headquartered in Motherwell, GB. | Health Technology |
| Bristol-Myers Squibb Foundation |
- Börse
- Insiders
- Sebastian Wanless
- Erfahrung